Intravenous sodium bicarbonate

Intravenous sodium bicarbonate
Clinical data
  • US: C (Risk not ruled out)
Routes of
Legal status
Legal status
Pharmacokinetic data
Bioavailability 100% (intravenous)
ChemSpider none
Chemical and physical data
Formula CHNaO3
Molar mass 84.01 g/mol
 NYesY (what is this?)  (verify)

Intravenous sodium bicarbonate (trade names including Baros) is a solution for intravenous administration that increases plasma bicarbonate, buffers excess hydrogen ion concentration, raises blood pH and reverses the clinical manifestations of acidosis.[1]


It is administered as a hypertonic solution of sodium bicarbonate, most commonly in concentrations of 4.2%, 5.0%, 7.5% or 8.4%.[1]

The solutions generally contain no antimicrobial agent or other added buffer.[1]

Mechanism of action

After injection, intravenous sodium bicarbonate dissociates to provide sodium (Na+) and bicarbonate (HCO3) anions. Bicarbonate anions can consume hydrogen ions (H+) and thereby be converted to carbonic acid (H2CO3), which can subsequently be converted to water (H2O) and carbon dioxide (CO2) which can be excreted by the lungs.[1]


Intravenous sodium bicarbonate is indicated in the treatment of metabolic acidosis, such as can occur in, for example, severe renal disease, diabetic ketoacidosis, circulatory insufficiency, extracorporeal circulation of blood, in hemolysis requiring alkalinization of the urine to avoid nephrotoxicity of blood pigments, and certain drug intoxications, such as by barbiturate overdose, salicylate poisoning, tricyclic antidepressant overdose or methanol poisoning.[1] In addition, sodium bicarbonate is indicated in severe diarrhea, where large amounts of bicarbonate may be lost.[1] However, overall treatment should also strive to treat the underlying cause of the acidosis, such as giving insulin in case of diabetic ketoacidosis.[1]



Intravenous sodium bicarbonate is contraindicated in patients who are losing chloride, such as by vomiting.[1]

Because of its sodium content, intravenous sodium bicarbonate should be used with great care, if at all, in patients with congestive heart failure and severe renal insufficiency, where low sodium intake is strongly indicated to prevent sodium retention.[1] By similar rationale, intravenous sodium bicarbonate should be given with caution to patients receiving corticosteroids.[1]


Overdose of intravenous sodium bicarbonate results in solute and/or fluid overload, potentially leading to edema, including pulmonary edema.[1] Also, it can cause metabolic alkalosis (with signs including muscular twitchings, irritability and tetany).[1] Hypernatremia is also possible.[1] Repeated fractional doses and frequent monitoring by laboratory tests are recommended to minimize the possibility of overdosing.[1]

Rapid administration (equal to or exceeding 10 mL/min) of intravenous sodium bicarbonate into neonates and children under two years of age may produce hypernatremia, resulting in a decrease in cerebrospinal fluid pressure and, possibly, intracranial hemorrhage. Therefore, the rate of administration to such patients should not exceed 8 mEq/kg/day, unless a very strong indication is present.[1]


Norepinephrine and dobutamine cannot be used as additives in an intravenous sodium bicarbonate solution.[1]

Intravenous sodium bicarbonate should not be mixed with calcium, as they may precipitate, except where compatibility has been previously established for the preparations at hand.[1]

Other adverse reactions

Extravasation of intravenous sodium bicarbonate has been reported to cause chemical cellulitis because of its alkalinity, resulting in tissue necrosis, ulceration and/or sloughing at the site of infiltration. This condition is managed by prompt elevation of the part, warmth and local injection of lidocaine or hyaluronidase.[1]


This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.